Levothyroxine Sodium
NDC 66336-337
Product Information
Levothyroxine Sodium is a NDA-approved product labeled by Dispensing Solutions, Inc.. Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It is supplied as a red product. This product entry covers the primary NDC 66336-337 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
JSP;562
Code Structure Chart
Product Details
What is NDC 66336-337?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LEVOTHYROXINE SODIUM ANHYDROUS (UNII: 054I36CPMN)
- LEVOTHYROXINE (UNII: Q51BO43MG4) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- LACTOSE (UNII: J2B2A4N98G)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- STARCH, CORN (UNII: O8232NY3SJ)
- ACACIA (UNII: 5C5403N26O)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- D&C RED NO. 27 (UNII: 2LRS185U6K)
- ALUMINUM OXIDE (UNII: LMI26O6933)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 892251 - levothyroxine sodium 200 MCG Oral Tablet
- RxCUI: 892251 - levothyroxine sodium 0.2 MG Oral Tablet
- RxCUI: 966248 - levothyroxine sodium 112 MCG Oral Tablet
- RxCUI: 966248 - levothyroxine sodium 0.112 MG Oral Tablet
- RxCUI: 966270 - levothyroxine sodium 137 MCG Oral Tablet
* Please review the full disclaimer at the bottom of this page.